Malignant Rectal Neoplasm — Trials

Malignant Rectal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,549 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 386
Recruiting: 215
Ph III recruiting: 36
Growth YoY: +9.8%
Industry share: 5%
Top sponsor: Fudan University
Termination share: 28%
Trials / 1,000 deaths: 29.9 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (153)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03594630	Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer	recruiting	Early Phase 1	120	M.D. Anderson Cancer CenterOTHER	1	May 20, 2026	clinicaltrials
NCT06645808	PET-imaging of Two Vartumabs in Patients With Solid Tumors(VARTUTRACE)	recruiting	Early Phase 1	32	Var2 PharmaceuticalsINDUSTRY	1	Dec 29, 2025	clinicaltrials